Simplex Trading’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

Simplex Trading’s Portfolio IRLA Stock Details IRLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20	Closed	-$404	–	10119
2026 Q1	$404	Buy	20 +17	+567%	+$3.41K	﹤0.01%	8760
2025 Q4	$1.68K	Buy	+3	New	+$1.51K	﹤0.01%	7888
2023 Q1	–	Sell	-415	Closed	-$52K	–	9918
2022 Q4	$52K	Buy	415 +1	+0.2%	+$167	﹤0.01%	5840
2022 Q3	$110K	Sell	414 -52	-11%	-$19.8K	﹤0.01%	5386
2022 Q2	$206K	Sell	466 -246	-35%	-$174K	﹤0.01%	4563
2022 Q1	$880K	Buy	712 +514	+260%	+$699K	﹤0.01%	3067
2021 Q4	$498K	Buy	198 +171	+633%	+$1.04M	﹤0.01%	3815
2021 Q3	$297K	Hold	27	–	–	﹤0.01%	4922
2021 Q2	$286K	Buy	+27	New	+$226K	﹤0.01%	5059
2021 Q1	–	Hold	0	–	–	–	8092
2020 Q4	–	Hold	0	–	–	–	6319

Other funds holding IRLA

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Simplex Trading's IRLA Position: Q2 2026 in Review

Simplex Trading sold out of IRulya Therapeutics Inc. Common Stock (IRLA) in Q2 2026, closing a stake of 770 shares — an estimated $15.6K sold.

Simplex Trading first reported a position in IRLA in Q3 2020 and held it in 10 quarters. The position peaked at $560K in Q4 2025. 26 funds tracked by Wall St. Rank hold IRLA as of Q2 2026.

Simplex Trading reported no remaining IRulya Therapeutics Inc. Common Stock position as of Q2 2026 after selling out during the quarter.
Simplex Trading sold 770 IRulya Therapeutics Inc. Common Stock shares in Q2 2026, an estimated $15.6K.
Simplex Trading first reported a position in IRulya Therapeutics Inc. Common Stock in Q3 2020 and held it in 10 quarters.
Simplex Trading's IRulya Therapeutics Inc. Common Stock position peaked at $560K in Q4 2025.
26 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.